Sep 24, 2026 01:26PM

Sep 12, 2026 04:00PM

Sep 9, 2026 07:28AM

Sep 8, 2026 01:25PM

Sep 8, 2026 10:53AM

Aug 5, 2026 04:35PM

Jul 28, 2026 06:44AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)

Jul 27, 2026 08:30AM

Jul 8, 2026 05:08PM

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM

Jun 30, 2026 08:30AM

Jun 18, 2026 06:11AM

May 6, 2026 04:46PM Sarepta Therapeutics (SRPT) Tops Q1 EPS by 217c

Apr 17, 2026 06:46AM

Mar 27, 2026 07:00PM

Mar 26, 2026 06:39AM

Mar 25, 2026 04:04PM

Mar 25, 2026 03:05PM

Mar 25, 2026 03:02PM

Mar 25, 2026 10:46AM Mizuho on Sarepta Therapeutics (SRPT): data de-risks siRNA platform, supports BIC potential

Mar 25, 2026 10:43AM

Mar 25, 2026 10:33AM

Mar 25, 2026 10:32AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM Sarepta plans regulatory submissions for two Duchenne drugs by April 2026

Mar 17, 2026 07:37AM

Mar 16, 2026 08:34AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 03:44PM

Mar 3, 2026 12:00PM

Mar 2, 2026 06:47AM Sarepta Therapeutics (SRPT) PT Lowered to $29 at Wedbush

Feb 26, 2026 08:30AM

Feb 25, 2026 04:45PM

Feb 24, 2026 09:08AM

Feb 4, 2026 08:30AM

Jan 27, 2026 06:43AM

Jan 26, 2026 12:54PM

Jan 26, 2026 08:01AM Sarepta reports positive three-year results for Duchenne gene therapy

Jan 26, 2026 05:30AM

Jan 26, 2026 05:18AM

Jan 23, 2026 04:05PM

Jan 14, 2026 06:55AM

Jan 14, 2026 04:39AM

Jan 12, 2026 11:59AM

Jan 12, 2026 09:30AM Johnson Fistel Investigates Sarepta Therapeutics, Inc. (SRPT) Directors for Potential Breaches of Fiduciary Duty

Jan 8, 2026 03:59AM

456,111 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All